Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].

Zhonghua nei ke za zhi - 1 Oct 2005

Wu Xi, Lu Xing-hua, Xu Tong, Qian Jia-ming, Zhao Ping, Guo Xiao-zhong, Yang Xiao-ou, Jiang Wei-jun

Abstract excerpt

OBJECTIVE: To evaluate the diagnostic value of serum carcinoma markers CA19-9, CA242, CA50 and carcinoembryonic antigens (CEA), fecal K-ras and p53 gene mutation in pancreatic cancer. METHODS: We collected 136 new cases of pancreatic cancer and 240 patients with benign digestive diseases including 49 patients with benign pancreatic diseases diagnosed in Peking Union Medical College Hospital, Chinese Academy of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoembryonic Antigen

Share to Genes, p53

Share to Genes, ras

Share to Pancreatic Neoplasms

Share to ROC Curve

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 16255879

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].PMID 16255879Read ↗

Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.Semantic proximity Read ↗

[Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].Semantic proximity Read ↗

[An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].Semantic proximity Read ↗

[Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].Semantic proximity Read ↗

[Clinical usefulness of tumor markers associated with pancreatic cancer].Semantic proximity Read ↗

Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.Semantic proximity Read ↗

Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.Semantic proximity Read ↗

A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer.Semantic proximity Read ↗

Clinical Diagnostic Value for Colorectal Cancer Based on Serum CEA, CA24-2 and CA19-9Semantic proximity Read ↗

Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer.Semantic proximity Read ↗

Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer.Semantic proximity Read ↗

Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.